Department of Surgery, University of Maryland School of Medicine, Baltimore, MD.
Surgery Service, Veterans Affairs Medical Centre, Baltimore, MD.
Ann Surg. 2023 Jun 1;277(6):920-928. doi: 10.1097/SLA.0000000000005515. Epub 2022 Jun 28.
Determine mid-term postoperative outcomes among coronavirus disease 2019 (COVID-19)-positive (+) patients compared with those who never tested positive before surgery.
COVID-19 is thought to be associated with prohibitively high rates of postoperative complications. However, prior studies have only evaluated 30-day outcomes, and most did not adjust for demographic, clinical, or procedural characteristics.
We analyzed data from surgeries performed at all Veterans Affairs hospitals between March 2020 and 2021. Kaplan-Meier curves compared trends in mortality and Cox proportional hazards models estimated rates of mortality and pulmonary, thrombotic, and septic postoperative complications between patients with a positive preoperative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test [COVID (+)] and propensity score-matched COVID-negative (-) patients.
Of 153,741 surgical patients, 4778 COVID (+) were matched to 14,101 COVID (-). COVID (+) status was associated with higher postoperative mortality ( P <0.0001) with a 6-month survival of 94.2% (95% confidence interval: 93.2-95.2) versus 96.0% (95% confidence interval: 95.7.0-96.4) in COVID (-). The highest mortality was in the first 30 postoperative days. Hazards for mortality and postoperative complications in COVID (+) decreased with increasing time between testing COVID (+) and date of surgery. COVID (+) patients undergoing elective surgery had similar rates of mortality, thrombotic and septic complications, but higher rates of pulmonary complications than COVID (-) patients.
This is the first report of mid-term outcomes among COVID-19 patients undergoing surgery. COVID-19 is associated with decreased overall and complication-free survival primarily in the early postoperative period, delaying surgery by 5 weeks or more reduces risk of complications. Case urgency has a multiplicative effect on short-term and long-term risk of postoperative mortality and complications.
与术前从未检测出新冠病毒(COVID-19)阳性的患者相比,确定 COVID-19 阳性(+)患者的中期术后结局。
COVID-19 被认为与术后并发症发生率过高有关。然而,先前的研究仅评估了 30 天的结果,且大多数研究未调整人口统计学、临床或手术特征。
我们分析了 2020 年 3 月至 2021 年期间在所有退伍军人事务部医院进行的手术数据。Kaplan-Meier 曲线比较了死亡率趋势,Cox 比例风险模型估计了 COVID-19 术前检测呈阳性(COVID +)患者与倾向评分匹配的 COVID-19 阴性(COVID -)患者之间的死亡率和肺部、血栓和脓毒症术后并发症的发生率。
在 153741 例手术患者中,4778 例 COVID +患者与 14101 例 COVID -患者相匹配。COVID +状态与较高的术后死亡率相关(P<0.0001),6 个月生存率为 94.2%(95%置信区间:93.2-95.2),而 COVID -患者为 96.0%(95%置信区间:95.7.0-96.4)。死亡率最高发生在术后 30 天内。COVID +患者的死亡风险和术后并发症风险随着检测到 COVID +到手术日期之间的时间增加而降低。接受择期手术的 COVID +患者的死亡率、血栓和脓毒症并发症发生率相似,但肺部并发症发生率高于 COVID -患者。
这是 COVID-19 患者接受手术的中期结果的首次报告。COVID-19 与总体和无并发症生存时间缩短有关,主要发生在术后早期,将手术推迟 5 周或更长时间可降低并发症风险。手术紧迫性对短期和长期术后死亡率和并发症风险有乘法效应。